US Patent 7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Patent 7399868 was granted and assigned to Allergan, Inc. on July, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
